Related Experiment Videos
Gangliosides and antitumor immunity
1Shemyakin Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow.
The Clinical Investigator
|August 1, 1993
Summary
Tumor-released gangliosides (GM3 and GD3) impair host immune defense by inhibiting natural killer cells and stimulating T-suppressor cells. These gangliosides modulate the arachidonic acid cascade, aiding tumor immune evasion.
Area of Science:
- Immunology
- Cancer Biology
- Biochemistry
Background:
- Circulating gangliosides from tumor cells may influence host immune defense.
- Elevated levels of GM3 and GD3 gangliosides are observed in tumor-bearing hosts.
Purpose of the Study:
- To investigate the effects of exogenous gangliosides on lymphocyte subpopulations.
- To understand the mechanisms of ganglioside-mediated immunomodulation in cancer.
Main Methods:
- Examined the impact of GM3 and GD3 gangliosides on natural killer cell cytotoxicity.
- Assessed the effects on T-suppressor cell activity and phytohemagglutinin-induced lymphocyte blast transformation.
- Investigated ganglioside modulation of the arachidonic acid cascade in lymphoid cells.
Main Results:
- GM3 and GD3 gangliosides strongly inhibited natural killer cell cytotoxicity.
- These gangliosides stimulated T-suppressor activity and inhibited lymphocyte blast transformation.
- Demonstrated ganglioside modulation of the arachidonic acid cascade in lymphoid cells.
Conclusions:
- Serum gangliosides can suppress host immune responses, including natural killer cell and T-cell functions.
- Gangliosides may facilitate tumor immune escape by inhibiting host immune surveillance.
- Modulation of the arachidonic acid cascade is a potential mechanism for ganglioside-induced immunomodulation.